PG vs RANI · P/E 25, rev $84.28B vs rev $1.0M
Procter & Gamble Company (PG) versus Rani Therapeutics Holdings Inc (RANI) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Rani Therapeutics Holdings Inc (RANI) is a biotechnology company listed on US.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Latest reported RANI revenue for 2024-12-31 was $1.0M. Net income was -$56.6M. RANI currently screens at market cap $41.5M.
PG currently screens at market cap $373.53B and trailing P/E 25.3. RANI currently screens at market cap $41.5M.
Not investment advice. Open the PG and RANI stock pages for the full models.
Not investment advice.